BackEstrella Immunopharma- Warrants (29/09/2028) Overview
Estrella Immunopharma Inc - Warrants (29/09/2028)

Estrella Immunopharma- Warrants (29/09/2028) PEG Ratio

Estrella Immunopharma- Warrants (29/09/2028) (ESLAW) has a PEG ratio of -23.39, below the sector sector average of -2.26.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-23.39

PEG Ratio

-23.39

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Estrella Immunopharma- Warrants (29/09/2028) (ESLAW) FAQ

Estrella Immunopharma- Warrants (29/09/2028) posts a PEG ratio of -23.39. That is below the sector sector average of -2.26. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a PEG ratio near -2.26 is typical. Estrella Immunopharma- Warrants (29/09/2028)'s -23.39 is lower that level. That is roughly 935.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Estrella Immunopharma- Warrants (29/09/2028)'s PEG ratio of -23.39 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for ESLAW's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -2.26), and (3) consistency with growth and profitability. This page covers the first two; Estrella Immunopharma- Warrants (29/09/2028)'s other metric pages and overview cover the third.